Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-03-23

Clinical Trial Update: Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study [Phase 2]

View source ↗

Summary

The document concerns a Phase 2 pilot study evaluating Exendin-4 for Parkinson's disease. It notes the sponsor and that the trial status is unknown with no resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exendin-4 (exendin-4)

Snippet

Sponsor: University College, London | Conditions: Parkinson's Disease | Phase 2 | Status: UNKNOWN